Dr. Yeong-Liang Lin has served as our Senior Vice President, Drug Safety and Pharmacovigilance since June 2022. From June 2020 to June 2022, he served as Vice President, Drug Safety and Pharmacovigilance at Vir Biotechnology. Previously, Dr. Lin held roles of increasing responsibility in drug safety at BeiGene, Genentech, Johnson & Johnson and the Center for Drug Evaluation in Taiwan. He completed his postgraduate medical training at the National Taiwan University Hospital. Dr. Lin holds an M.D. from National Taiwan University and an M.S. in Epidemiology from Harvard University.